LinXis BV - Company Review
LinXis BV - Company ReviewSummary
LinXis BV (LinXis) is a drug development company that develops cancer treatment drugs. The company’s Lx technology can be armed with highly potent drugs and allows for their facile coordination to target proteins such as antibodies. Its Lx technology offers control over site of conjugation, improved aqueous solubility, excellent stability, mild reaction conditions, no modification of protein required, robust conjugation compatible with wide variety of buffer systems, uncompromized affinity of antibody conjugates and tracking of conjugates with inductively coupled plasma mass spectrometry. The company operates lab facilities in Amsterdam. LinXis is headquartered in Amsterdam, the Netherlands.
This comprehensive company report of LinXis BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.